Active/ Exited

We are a biopharmaceutical company providing transformative therapeutic solutions to patients and their families with rare and high disease burden conditions

ViroPharma Incorporated was a pharmaceutical company that developed and sold drugs that addressed serious diseases treated by physician specialists and in hospital settings. Acquired by Shire

Verona Pharma plc is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative prescription medicines to treat respiratory diseases with significant unmet medical needs, such as COPD, cystic fibrosis and asthma.

Trevena is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by Central Nervous System (CNS) conditions.

Tokai Pharmaceuticals (NASDAQ: TKAI), based in Boston, Massachusetts, is focused on translating innovative science to develop and deliver innovative therapies that provide hope and healing for patients living with cancer.

Tianyin Pharmaceutical was set up in 1994 and now is based in Cheng Du, China. The company focuses on biopharmaceutical medicines, famous for its generics, traditional Chinese medicines.

Company specializes in research & development of health products delivery system, especially nasal products delivery system.

Suzhou Pharmaceutical Group Co. Ltd. manufactures and distributes pharmaceutical products. The Company produces antibiotics, estrogenic agents, nonsteroidal anti-inflammatory agents, antipyretic analgesics, and other medical products.

Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics.

Strongbridge Biopharma plc (NASDAQ: SBBP) is a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs.